NIH-funded research NIH-funded research

New methods to find small molecules that interact with proteins

Official title: Novel platforms for the discovery of bioactive small molecules

Funded at University of Florida · NIH-11014463 · Data updated 2026-11-12

This study is exploring new ways to find tiny molecules that can help control proteins in our cells, which could lead to new treatments for aging and diseases, and it's designed for anyone interested in how we can improve health through better drug development.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startFebruary 1, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$565,112
NIH project number5R35GM151875-02
Project IDNIH-11014463 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from degenerative diseases or conditions related to aging.

Less likely to help

Patients with acute conditions unrelated to protein regulation or aging may not benefit from this research.

What this research studies

This research focuses on developing innovative techniques to discover small molecules that can bind to proteins, particularly those involved in the Ubiquitin Proteasome System, which is essential for protein regulation in cells. By using DNA-encoded library technology, the researchers will create libraries of these small molecules on tiny beads and screen them with labeled proteins to identify potential drug leads. The goal is to find new compounds that can help manipulate the proteasome, which may lead to treatments for aging and degenerative diseases. Additionally, the research aims to create a new class of drugs that can directly target proteins for degradation without needing prior modification.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for aging-related conditions and degenerative diseases by improving protein regulation in cells.

How similar studies have gone: Other research has successfully utilized DNA-encoded library technology for drug discovery, indicating a promising approach in this area.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Kodadek, Thomas J. — University of Florida
  • Study coordinator: Kodadek, Thomas J.

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.